Medicare

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...

Elite Medicare Specialists Partners with Integrity to Optimize Operational Performance and Better Reach Underserved Communities

Integrity's full-stack platform provides Elite Medicare Specialists with cutting-edge technology and supportive resources designed to streamline service efficiencies DALLAS, Aug....

error: Content is protected !!